Raleigh biopharma company FLAG Therapeutics Inc. has achieved a milestone with a U.S. Food & Drug Administration designation for the company’s investigational treatment for a rare brain tumor in children.
Read More
Scientists at UNC have made the surprising discovery that a molecule called EdU, which is commonly used in laboratory experiment is in fact recognized by human cells as DNA damage, triggering a runaway process of DNA repair that is eventually fatal to affected cells, including cancer cells.
Read More
Scientists at the UNC School of Medicine and the UNC Lineberger Comprehensive Cancer Center have uncovered a possible reason why certain breast cancers are so aggressive.
Read More
A Raleigh-based oncology company researching treatments for deadly cancers, has raised $1.3 million.
Read More
A startup launched by Duke brain cancer scientists has achieved rare positive results in a treatment for the type of brain cancer killing Senator John McCain and that took the life of Senator Ted Kennedy.
Read MoreCranioVation, which has developed an innovative way to treat brain tumors using light delivered via a minimally invasive device, has raised nearly $650,000 in equity, according to a securities filing.
Read More
